Trinity Point Wealth, LLC Abb Vie Inc. Transaction History

Trinity Point Wealth, LLC

$680 Million
Q3 2024

A detailed history of Trinity Point Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Trinity Point Wealth, LLC holds 57,851 shares of ABBV stock, worth $10.2 Million. This represents 1.68% of its overall portfolio holdings.

Number of Shares

57,851

Previous 57,820 0.05%

Holding current value

$10.2 Million

Previous $9.92 Million 15.2%

% of portfolio

1.68%

Previous 1.58%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$163.84 - $199.33 $5,079 - $6,179	31 Added 0.05%	57,851 $11.4 Million
Q2 2024 Jul 30, 2024	SELL	$154.79 - $180.76 $133,583 - $155,995	-863 Reduced 1.47%	57,820 $9.92 Million
Q1 2024 May 08, 2024	BUY	$159.82 - $182.1 $104,362 - $118,911	653 Added 1.13%	58,683 $10.7 Million
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $571,177 - $643,280	-4,151 Reduced 6.68%	58,030 $8.99 Million
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $88,970 - $102,996	666 Added 1.08%	62,181 $9.27 Million
Q2 2023 Aug 07, 2023	BUY	$132.51 - $164.9 $168,685 - $209,917	1,273 Added 2.11%	61,515 $8.29 Million
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $190,017 - $218,833	1,314 Added 2.23%	60,242 $9.6 Million
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $50,759 - $60,874	367 Added 0.63%	58,928 $9.53 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $21,607 - $24,782	161 Added 0.28%	58,561 $7.86 Million
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $607,729 - $772,623	4,416 Added 8.18%	58,400 $8.95 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $480,407 - $596,050	3,640 Added 7.23%	53,984 $8.75 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $15,469 - $19,573	144 Added 0.29%	50,344 $6.82 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $84,588 - $96,020	795 Added 1.61%	50,200 $5.42 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $44,503 - $49,579	423 Added 0.86%	49,405 $5.57 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $44,602 - $49,102	436 Added 0.9%	48,982 $5.3 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $1.29 Million - $1.75 Million	16,065 Added 49.46%	48,546 $5.28 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $1.7 Million - $1.99 Million	19,784 Added 155.82%	32,481 $2.85 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $13,573 - $18,163	185 Added 1.48%	12,697 $1.25 Million
Q1 2020 May 05, 2020	BUY	$64.5 - $97.79 $102,039 - $154,703	1,582 Added 14.47%	12,512 $953,000
Q4 2019 Feb 06, 2020	SELL	$72.13 - $90.25 $440,642 - $551,337	-6,109 Reduced 35.85%	10,930 $968,000
Q3 2019 Nov 07, 2019	BUY	$62.98 - $75.72 $611,157 - $734,786	9,704 Added 132.3%	17,039 $1.41 Million
Q2 2019 Aug 06, 2019	SELL	$65.7 - $83.98 $10,840 - $13,856	-165 Reduced 2.2%	7,335 $495,000
Q1 2019 May 07, 2019	BUY	$77.14 - $90.79 $345,510 - $406,648	4,479 Added 148.26%	7,500 $604,000
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $235,184 - $290,046	3,021 New	3,021 $278,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trinity Point Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trinity Point Wealth, LLC with notifications on news.

Account

Trinity Point Wealth, LLC Abb Vie Inc. Transaction History